CUSIP: 92852W204
Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
28,199,310
-
Share change
-
+10,493,617
-
Total reported value
-
$29,601,080
-
Price per share
-
$1.05
-
Number of holders
-
41
-
Value change
-
+$10,660,563
-
Number of buys
-
19
-
Number of sells
-
19
Quarterly Holders Quick Answers
What is CUSIP 92852W204?
CUSIP 92852W204 identifies VIVE - VIVEVE MED INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2019
-
Previous quarter:
Q3 2018
Recent filing periods for CUSIP 92852W204:
Institutional Holders of VIVEVE MED INC - COM NEW (VIVE) as of Q4 2018
As of 31 Dec 2018,
VIVEVE MED INC - COM NEW (VIVE) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,199,310 shares.
The largest 10 holders included
Nantahala Capital Management, LLC, RTW INVESTMENTS, LP, Stonepine Capital Management, LLC, Hood River Capital Management LLC, UBS Group AG, HighTower Advisors, LLC, Vanguard Group Inc, MEITAV DASH INVESTMENTS LTD, BlackRock Inc., and Polar Capital LLP.
This page lists
41
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.